Position in CGC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$140,452
+$53,582 QoQ
Shares Held
148,000
+770.6% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$234,308
PutShares
246,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Verition Fund Management LLC holds $14,533,555 across 10 Drug Manufacturers - Specialty & Generic names. CGC ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
211,287 | $5,056,097 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
60,000 | $4,551,000 | |
| 3 | LQDA |
Liquidia Corp
|
60,111 | $2,268,589 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
29,919 | $676,169 | |
| 5 | VTRS |
Viatris Inc
|
39,928 | $539,427 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
13,362 | $402,463 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
18,597 | $364,315 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
10,604 | $350,674 |
All Filings in CGC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $234,308 | 246,900 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $140,452 | 148,000 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $887,096 | 173,600 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $86,870 | 17,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||